Published in Gut on February 14, 2008
Obesity and nonalcoholic fatty liver disease: biochemical, metabolic, and clinical implications. Hepatology (2010) 5.35
In vivo characterization of the liver fat ¹H MR spectrum. NMR Biomed (2010) 3.07
Severe NAFLD with hepatic necroinflammatory changes in mice fed trans fats and a high-fructose corn syrup equivalent. Am J Physiol Gastrointest Liver Physiol (2008) 2.45
High-fat and high-sucrose (western) diet induces steatohepatitis that is dependent on fructokinase. Hepatology (2013) 1.56
Nutrition and physical activity in NAFLD: an overview of the epidemiological evidence. World J Gastroenterol (2011) 1.48
Obesity, diabetes mellitus, and liver fibrosis. Am J Physiol Gastrointest Liver Physiol (2011) 1.24
Effect of fructose on markers of non-alcoholic fatty liver disease (NAFLD): a systematic review and meta-analysis of controlled feeding trials. Eur J Clin Nutr (2014) 1.20
Regulation of the fibrosis and angiogenesis promoter SPARC/osteonectin in human adipose tissue by weight change, leptin, insulin, and glucose. Diabetes (2009) 1.13
Short-term overeating induces insulin resistance in fat cells in lean human subjects. Mol Med (2009) 1.00
Pediatric non-alcoholic fatty liver disease: an increasing public health issue. Eur J Pediatr (2013) 1.00
Reexamining transaminase elevation in Phase I clinical trials: the importance of baseline and change from baseline. Eur J Clin Pharmacol (2009) 0.98
Implications of diet on nonalcoholic fatty liver disease. Curr Opin Gastroenterol (2010) 0.96
Liver enzymes, metabolomics and genome-wide association studies: from systems biology to the personalized medicine. World J Gastroenterol (2015) 0.96
Nonalcoholic fatty liver disease and cardiovascular risk. Curr Gastroenterol Rep (2009) 0.93
Combination of alcohol and fructose exacerbates metabolic imbalance in terms of hepatic damage, dyslipidemia, and insulin resistance in rats. PLoS One (2014) 0.92
Dietary fructose reduction improves markers of cardiovascular disease risk in Hispanic-American adolescents with NAFLD. Nutrients (2014) 0.92
Dietary habits and behaviors associated with nonalcoholic fatty liver disease. World J Gastroenterol (2014) 0.91
Current concepts and management approaches in nonalcoholic fatty liver disease. ScientificWorldJournal (2013) 0.91
Hepatotoxicity of fast food? Gut (2008) 0.91
Lifestyle changes for the treatment of nonalcoholic fatty liver disease: a review of observational studies and intervention trials. Therap Adv Gastroenterol (2016) 0.90
Beneficial effect of a weight-stable, low-fat/low-saturated fat/low-glycaemic index diet to reduce liver fat in older subjects. Br J Nutr (2012) 0.88
Prospective histopathologic evaluation of lifestyle modification in nonalcoholic fatty liver disease: a randomized trial. Therap Adv Gastroenterol (2013) 0.88
Dietary trans-fatty acid induced NASH is normalized following loss of trans-fatty acids from hepatic lipid pools. Lipids (2012) 0.86
Advances in the treatment of nonalcoholic fatty liver disease. Ther Adv Endocrinol Metab (2010) 0.86
A randomized, placebo-controlled trial to determine the course of aminotransferase elevation during prolonged acetaminophen administration. BMC Pharmacol Toxicol (2014) 0.85
Dietary patterns in Brazilian patients with nonalcoholic fatty liver disease: a cross-sectional study. Clinics (Sao Paulo) (2013) 0.83
NASH: Thiazolidinediones for NASH--one pill doesn't fix everything. Nat Rev Gastroenterol Hepatol (2010) 0.81
Incretin based therapies: a novel treatment approach for non-alcoholic fatty liver disease. World J Gastroenterol (2014) 0.81
Management of non-alcoholic fatty liver disease in 2015. World J Hepatol (2015) 0.81
Long-term increase of fat mass after a four week intervention with fast food based hyper-alimentation and limitation of physical activity. Nutr Metab (Lond) (2010) 0.78
Meta-analysis of the influence of TM6SF2 E167K variant on Plasma Concentration of Aminotransferases across different Populations and Diverse Liver Phenotypes. Sci Rep (2016) 0.77
Association between inflammatory markers and liver fat: The Multi-Ethnic Study of Atherosclerosis. J Clin Exp Cardiolog (2015) 0.77
A Randomized Study of the Effects of Additional Fruit and Nuts Consumption on Hepatic Fat Content, Cardiovascular Risk Factors and Basal Metabolic Rate. PLoS One (2016) 0.75
Intrahepatic and extrahepatic aminotransferase elevation associated with clinical-therapeutic events in a schizophrenic patient. Clin Case Rep (2016) 0.75
Effects of exercise with or without blueberries in the diet on cardio-metabolic risk factors: an exploratory pilot study in healthy subjects. Ups J Med Sci (2013) 0.75
Fast-food hyper-alimentation and exercise restriction in healthy subjects. Gut (2009) 0.75
Fast Food Pattern and Cardiometabolic Disorders: A Review of Current Studies. Health Promot Perspect (2016) 0.75
High-Fat and Fat-Enriched Diets Impair the Benefits of Moderate Physical Training in the Aorta and the Heart in Rats. Front Nutr (2017) 0.75
Elevation of alanine transaminase and markers of liver fibrosis after a mixed meal challenge in individuals with type 2 diabetes. Dig Dis Sci (2012) 0.75
Nonalcoholic fatty liver disease. N Engl J Med (2002) 22.41
Prevalence of hepatic steatosis in an urban population in the United States: impact of ethnicity. Hepatology (2004) 18.86
Updated definitions of healthy ranges for serum alanine aminotransferase levels. Ann Intern Med (2002) 10.78
Long-term follow-up of patients with NAFLD and elevated liver enzymes. Hepatology (2006) 10.05
Homeostasis model assessment closely mirrors the glucose clamp technique in the assessment of insulin sensitivity: studies in subjects with various degrees of glucose tolerance and insulin sensitivity. Diabetes Care (2000) 9.10
Magnetic resonance spectroscopy to measure hepatic triglyceride content: prevalence of hepatic steatosis in the general population. Am J Physiol Endocrinol Metab (2004) 8.36
The prevalence and etiology of elevated aminotransferase levels in the United States. Am J Gastroenterol (2003) 8.23
The natural history of nonalcoholic steatohepatitis: a follow-up study of forty-two patients for up to 21 years. Hepatology (1990) 6.53
Association of nonalcoholic fatty liver disease with insulin resistance. Am J Med (1999) 5.65
Nonalcoholic steatohepatitis: an expanded clinical entity. Gastroenterology (1994) 5.22
Proton MR spectroscopy in quantitative in vivo determination of fat content in human liver steatosis. J Magn Reson Imaging (1995) 2.77
Prospective evaluation of unexplained chronic liver transaminase abnormalities in asymptomatic and symptomatic patients. Am J Gastroenterol (1999) 2.54
Findings on liver biopsy to investigate abnormal liver function tests in the absence of diagnostic serology. J Hepatol (2001) 2.43
Elevations in markers of liver injury and risk of type 2 diabetes: the insulin resistance atherosclerosis study. Diabetes (2004) 2.08
The clinical significance of slightly to moderately increased liver transaminase values in asymptomatic patients. Scand J Gastroenterol (1999) 1.69
Alcohol-induced hepatic injury in nonalcoholic volunteers. N Engl J Med (1968) 1.65
Serum alanine aminotransferase (ALT) elevation in asymptomatic US Air Force basic trainee blood donors. Dig Dis Sci (1993) 1.64
Dietary composition and nonalcoholic fatty liver disease. Dig Dis Sci (2004) 1.46
The yield of multiphasic screening. JAMA (1972) 1.35
Nonalcoholic steatohepatitis. Semin Liver Dis (1999) 1.32
Insulin resistance, adiponectin, cytokines in NASH: Which is the best target to treat? J Hepatol (2005) 1.31
Elevated AST or ALT to nonalcoholic fatty liver disease: accurate predictor of disease prevalence? Am J Gastroenterol (2003) 1.16
Assessing the outcome of nonalcoholic steatohepatitis? It's time to get serious. Hepatology (2006) 1.15
Reference intervals for eight enzymes in blood of adult females and males measured in accordance with the International Federation of Clinical Chemistry reference system at 37 degrees C: part of the Nordic Reference Interval Project. Scand J Clin Lab Invest (2004) 1.03
Changes in basal metabolic rate during pregnancy in relation to changes in body weight and composition, cardiac output, insulin-like growth factor I, and thyroid hormones and in relation to fetal growth. Am J Clin Nutr (2005) 1.01
Evaluation of blood donors with elevated serum alanine aminotransferase levels. Ann Intern Med (1987) 0.97
Prolonged administration of ethanol to young, healthy volunteers: effects on biochemical, morphological and neurophysiological parameters. Acta Med Scand Suppl (1973) 0.96
Biochemistry of well populations. Lancet (1974) 0.88
Serum-enzyme activities, cholesterin, and triglycerides in serum after intake of alcohol. Scand J Clin Lab Invest Suppl (1966) 0.83
Global patterns of diversity and community structure in marine bacterioplankton. Mol Ecol (2007) 3.50
Roles for insulin receptor, PI3-kinase, and Akt in insulin-signaling pathways related to production of nitric oxide in human vascular endothelial cells. Circulation (2000) 2.59
Effect of hypnotherapy and educational intervention on brain response to visceral stimulus in the irritable bowel syndrome. Aliment Pharmacol Ther (2013) 2.26
Estimating individual contributions to population growth: evolutionary fitness in ecological time. Proc Biol Sci (2006) 2.25
Rapid magnetic resonance quantification on the brain: Optimization for clinical usage. Magn Reson Med (2008) 1.73
From arctic lemmings to adaptive dynamics: Charles Elton's legacy in population ecology. Biol Rev Camb Philos Soc (2001) 1.70
Population dynamics and the colour of environmental noise. Proc Biol Sci (1997) 1.65
Enzymatic hydrolysis combined with mechanical shearing and high-pressure homogenization for nanoscale cellulose fibrils and strong gels. Biomacromolecules (2007) 1.62
Novel method for rapid, simultaneous T1, T2*, and proton density quantification. Magn Reson Med (2007) 1.49
Functional characterization of osteoblasts and osteoclasts from alkaline phosphatase knockout mice. J Bone Miner Res (2000) 1.35
Detection of neural activity in functional MRI using canonical correlation analysis. Magn Reson Med (2001) 1.31
Dispersal, migration, and offspring retention in saturated habitats. Am Nat (2001) 1.30
Trophic and individual efficiencies of size-structured communities. Proc Biol Sci (2009) 1.21
Visibility of the environmental noise modulating population dynamics. Proc Biol Sci (2000) 1.21
Direct comparison of insulin lispro and aspart shows small differences in plasma insulin profiles after subcutaneous injection in type 1 diabetes. Diabetes Care (2001) 1.17
Disordered methionine/homocysteine metabolism in premature vascular disease. Its occurrence, cofactor therapy, and enzymology. Arterioscler Thromb (1993) 1.15
A general theory of environmental noise in ecological food webs. Am Nat (1998) 1.15
Insulin-induced GLUT4 translocation to the plasma membrane is blunted in large compared with small primary fat cells isolated from the same individual. Diabetologia (2007) 1.11
In type 2 diabetes, randomisation to advice to follow a low-carbohydrate diet transiently improves glycaemic control compared with advice to follow a low-fat diet producing a similar weight loss. Diabetologia (2012) 1.07
Effects of enrichment on simple aquatic food webs. Am Nat (2001) 1.05
Masked nocturnal hypertension--a novel marker of risk in type 2 diabetes. Diabetologia (2009) 1.03
Gender influences herpes simplex virus type 1 infection in normal and gamma interferon-mutant mice. J Virol (2001) 1.02
Ammonia permeability of erythrocyte membrane studied by 14N and 15N saturation transfer NMR spectroscopy. Am J Physiol (1995) 0.97
IL-1beta and TNF-alpha regulate IL-6-type cytokines in gingival fibroblasts. J Dent Res (2008) 0.95
A comparison a amitriptyline and maprotiline in the treatment of painful polyneuropathy in diabetics and nondiabetics. Clin J Pain (1997) 0.93
Synthetic MRI of the brain in a clinical setting. Acta Radiol (2012) 0.93
Benzene: standards, occurrence, and exposure. Am J Ind Med (1985) 0.92
Carotid intima-media thickness and apolipoprotein B/apolipoprotein A-I ratio in middle-aged patients with Type 2 diabetes. Diabet Med (2009) 0.92
Pedometer-determined physical activity is linked to low systemic inflammation and low arterial stiffness in Type 2 diabetes. Diabet Med (2012) 0.92
Novel whole brain segmentation and volume estimation using quantitative MRI. Eur Radiol (2011) 0.91
Quantifying differences in hepatic uptake of the liver specific contrast agents Gd-EOB-DTPA and Gd-BOPTA: a pilot study. Eur Radiol (2011) 0.91
Right-hemispheric brain activation correlates to language performance. Neuroimage (2009) 0.90
Insulin stimulates increased catalytic activity of phosphoinositide-dependent kinase-1 by a phosphorylation-dependent mechanism. Biochemistry (2001) 0.90
Weight gain by hyperalimentation elevates C-reactive protein levels but does not affect circulating levels of adiponectin or resistin in healthy subjects. Eur J Endocrinol (2010) 0.89
The insulin-like growth factor system in vascular smooth muscle: interaction with insulin and growth factors. Metabolism (1995) 0.88
Men develop more intraabdominal obesity and signs of the metabolic syndrome after hyperalimentation than women. Metabolism (2009) 0.88
TP10, a delivery vector for decoy oligonucleotides targeting the Myc protein. J Control Release (2005) 0.87
Reduction of ACE activity is insufficient to decrease microalbuminuria in normotensive patients with type 1 diabetes. Diabetes Care (2001) 0.86
Procedure for quantitative (1)H magnetic resonance spectroscopy and tissue characterization of human brain tissue based on the use of quantitative magnetic resonance imaging. Magn Reson Med (2012) 0.86
Low choline concentrations in normal-appearing white matter of patients with multiple sclerosis and normal MR imaging brain scans. AJNR Am J Neuroradiol (2007) 0.85
Treatment with insulin lispro changes the insulin profile but does not affect the plasma concentrations of IGF-I and IGFBP-1 in type 1 diabetes. Clin Endocrinol (Oxf) (2001) 0.85
Non-invasive monitoring of gingival crevicular fluid for estimation of blood glucose level. Med Biol Eng Comput (2004) 0.85
Hamilton's rule confronts ideal free habitat selection. Proc Biol Sci (2001) 0.85
Decreased muscle concentrations of ATP and PCR in the quadriceps muscle of fibromyalgia patients--a 31P-MRS study. Eur J Pain (2013) 0.84
A predator-prey model with optimal suppression of reproduction in the prey. Math Biosci (1996) 0.83
Diabetes control in Swedish community dwelling elderly: more often tight than poor. J Intern Med (2004) 0.83
Scaling of the mean and variance of population dynamics under fluctuating regimes. Theory Biosci (2014) 0.83
Serum leptin concentrations in a normal population and in GH deficiency: negative correlation with testosterone in men and effects of GH treatment. Clin Endocrinol (Oxf) (1997) 0.83
Stimulation of IL-6 cytokines in fibroblasts by toll-like receptors 2. J Dent Res (2010) 0.82
Microisolated mouse osteoclasts express VIP-1 and PACAP receptors. Biochem Biophys Res Commun (2000) 0.80
Perturbation of DNA hairpins containing the EcoRI recognition site by hairpin loops of varying size and composition: physical (NMR and UV) and enzymatic (EcoRI) studies. Nucleic Acids Res (1990) 0.80
The significance of neurobehavioral tests for occupational exposure limits: an example from Sweden. Neurotoxicology (2000) 0.80
Peroxisome proliferator activated receptor gamma activity is low in mature primary human visceral adipocytes. Diabetologia (2006) 0.79
Mitochondrial inner membrane changes determined by cross partition. Biochem Biophys Res Commun (1975) 0.79
Reduced thalamic N-acetylaspartate in idiopathic normal pressure hydrocephalus: a controlled 1H-magnetic resonance spectroscopy study of frontal deep white matter and the thalamus using absolute quantification. J Neurol Neurosurg Psychiatry (2011) 0.79
IL-4 and IL-13 inhibit IL-1β and TNF-α induced kinin B1 and B2 receptors through a STAT6-dependent mechanism. Br J Pharmacol (2013) 0.78
Deficient habituation to repeated rectal distensions in irritable bowel syndrome patients with visceral hypersensitivity. Neurogastroenterol Motil (2015) 0.78
Self-organized dynamics in spatially structured populations. Proc Biol Sci (2001) 0.78
A dose titration model for recombinant GH substitution aiming at normal plasma concentrations of IGF-I in hypopituitary adults. Eur J Endocrinol (2002) 0.78
The snack is critical for the blood glucose profile during treatment with regular insulin preprandially. J Intern Med (1999) 0.77
Transient increase in HDL-cholesterol during weight gain by hyperalimentation in healthy subjects. Obesity (Silver Spring) (2010) 0.77
The renin-angiotensin-aldosterone system is suppressed in adults with Type 1 diabetes. J Renin Angiotensin Aldosterone Syst (2000) 0.77
Combination-therapy with bedtime nph insulin and sulphonylureas gives similar glycaemic control but lower weight gain than insulin twice daily in patients with type 2 diabetes. Diabetes Metab (2002) 0.77
Helodermin, helospectin, and PACAP stimulate cyclic AMP formation in intact bone, isolated osteoblasts, and osteoblastic cell lines. Calcif Tissue Int (1994) 0.76
Assessment and management of occupational risks in the Nordic (Scandinavian) countries. Am J Ind Med (1989) 0.76
Cognitive behavior therapy-based psychoeducational groups for adults with ADHD and their significant others (PEGASUS): an open clinical feasibility trial. Atten Defic Hyperact Disord (2014) 0.75
Phosphorus-31 NMR Studies of Cell Wall-Associated Calcium-Phosphates in Ulva lactuca. Plant Physiol (1989) 0.75
[Unclear about survival and mortality]. Lakartidningen (1995) 0.75
Behavioral effects of early deprivation of nerve growth factor: some similarities with familial dysautonomia. Brain Res (1982) 0.75
NAD + -induced phosphate acceptor specificity in submitochondrial systems. Biochim Biophys Acta (1972) 0.75
[Hepatic clearence of 133Xe and 85Kr in dog]. Nord Med (1971) 0.75
Post-mortem energy metabolism in bovine muscles studied by non-invasive phosphorus-31 nuclear magnetic resonance. Meat Sci (2005) 0.75
Optical scattering from rough-rolled aluminum surfaces. Appl Opt (2001) 0.75
ATP- and phosphate-induced configurational changes of submitochondrial particles. Biochim Biophys Acta (1975) 0.75
NAD+ induced nucleoside specificity of oxidative phosphorylation. Biochem Biophys Res Commun (1969) 0.75
Effects of waste incineration combustion emissions measured by some toxicity test systems. Toxicol Lett (1984) 0.75
Environmental fluctuations and level of density-compensation strongly affects the probability of fixation and fixation times. Bull Math Biol (2010) 0.75
Succinate oxidation in hamster brown adipocytes. Experientia Suppl (1978) 0.75
Heparin in vivo effect on free thyroxin. Clin Chem (1982) 0.75
Flavoprotein-linked substrate oxidation in preparations of hamster brown adipocytes. A discrimination between internally and externally oxidized substrates. Biochim Biophys Acta (1979) 0.75
Swedish occupational exposure limits: developments in scientific evaluation and documentation. Am J Ind Med (1988) 0.75
Charge qubit coupled to an intense microwave electromagnetic field in a superconducting Nb device: evidence for photon-assisted quasiparticle tunneling. Phys Rev Lett (2013) 0.75
International round-robin experiment to test the International Organization for Standardization total-scattering draft standard. Appl Opt (2000) 0.75
Phosphate acceptor specificity during oxidative phosphorylation in submitochondrial particles. Biochim Biophys Acta (1972) 0.75
[OP.1D.01] DIASTOLIC ORTHOSTATIC HYPERTENSION PREDICTS A FAVORABLE CARDIOVASCULAR PROGNOSIS IN TYPE 2 DIABETES. J Hypertens (2016) 0.75
[Bronchopneumonia]. Lakartidningen (1980) 0.75
Efficacy, tolerance and hormonal effects of a new oral angiotensin converting enzyme inhibitor, ramipril (HOE 498), in mild to moderate primary hypertension. Am J Cardiol (1987) 0.75
Reverse triiodothyronine in screening for congenital hypothyroidism. Lancet (1976) 0.75
Detoxication disturbances and uncoupling effects in vitro of some chlorinated guaiacols, catechols and benzoquinones. Chem Biol Interact (1980) 0.75
[The HIV situation in Stockholm 1991. The Swedish model prevents epidemic]. Lakartidningen (1992) 0.75
Sustained improvement of glycemic control by insulin treatment after 9 years in patients with type 2 diabetes and secondary failure. Diabetes Care (1999) 0.75
[The list of maximum permissible levels contains a lot of new hazardous substances]. Lakartidningen (1994) 0.75